Neuron23 Inc gathers $113.5m

Neuron23 Inc, an early-stage biotechnology company, has raised $113.5 million in funding.

Neuron23 Inc, an early-stage biotechnology company, has raised $113.5 million in funding. The company’s backers include Westlake Village BioPartners, Kleiner Perkins and Redmile Group.

Source: Press Release